NDC 82292-040-01 - LUMISIGHT
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82292-040
- Requested NDC
- 82292-040-01
- Package NDCs from labels
- 82292-040-01, 82292-040-10
- Manufacturer
- Lumicell, Inc.
- Effective date
- 2026-01-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LUMISIGHT - Lumicell, Inc. | Lumicell, Inc. | 2026-01-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82292-040-01 | LUMISIGHT | 3.9 mL in 1 VIAL | Injection, powder, lyophilized, | 3.9 | 3 | |
| 82292-040-10 | LUMISIGHT | 10 in 1 CARTON | Injection, powder, lyophilized, | 10 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 82292-040-01 | EA - Each | 82292-040 | 5210a929-a7fa-4725-9470-fe0be48fa84a | 1 | 2024-06-10 |
| 82292-040-10 | EA - Each | 82292-040 | d4690cf3-9f57-4720-bb2a-a43e673a6ebd | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | ee831456-5962-4d5e-ad0c-69ab85860453 | 2020-06-03 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | 593YOG76RN | |
| Acid Reflux Relief | CAPSICUM, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, STRYCHNOS NUX-VOMICA SEED, ROBINIA PSEUDOACACIA BARK, SULFUR, SEPIA OFFICINALIS JUICE | Homeocare Laboratories | 01ddf3ee-e925-404d-9b41-7876d5fd6634 | 2019-03-20 | Warnings | 70WT22SF4B |
| Candida | BAPTISIA TINCTORIA, ECHINACEA PURP, GLYCYRRHIZA GLABRA, ASTRAGALUS, CANDIDA ALB, BORAX, CALC CARB, KREOSOTUM, LYCOPODIUM, NUX VOM, PHOSPHORICUM AC, PULSATILLA, SEPIA, THUJA OCC, NAT PHOS, NITRICUM AC | Zorex International | c6595326-6d04-499e-9eb7-0a4cd2ba48fd | 2018-12-21 | Warnings | 70WT22SF4B |
| GB-Tone | AMMI VISNAGA, ATROPINUM SULPHURICUM, BOLDO, CARDUUS MARIANUS, CHELIDONIUM MAJUS, ECHINACEA, FEL TAURI, HEPAR SUIS, HYDRASTIS CANADENSIS, LEPTANDRA VIRGINICA, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM, PODOPHYLLUM PELTATUM, TARAXACUM OFFICINALE | Energetix Corp | 5620a1dc-b59c-4489-a548-20f3e488287f | 2018-07-11 | Warnings | 70WT22SF4B |
| Metabolic Support | FUCUS VESICULOSUS, AGNUS CASTUS, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHYTOLACCA DECANDRA, KALI PHOSPHORICUM, MAGNESIA PHOSPHORICA, CARBO VEGETABILIS, GRAPHITES, CALCAREA CARBONICA, NATRUM PHOSPHORICUM, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, THYROIDINUM (SUIS) | BodyLogicMD of Fort Lauderdale | c2a1bd6d-c595-402f-a3bc-23f64c949d78 | 2018-06-08 | Warnings | 70WT22SF4B |
| URELLE | HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Viatris Specialty LLC | 1d80a11c-6f86-403b-85d4-32ec1924dbe9 | 2015-01-13 | Warnings, Adverse reactions | 593YOG76RN |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | 593YOG76RN | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 70WT22SF4B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.